These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 3297316

  • 1. Early parkinsonism.
    Calne DB, Stoessl AJ.
    Clin Neuropharmacol; 1986; 9 Suppl 2():S3-8. PubMed ID: 3297316
    [Abstract] [Full Text] [Related]

  • 2. Toxins and Parkinson's disease: MPTP parkinsonism in humans and animals.
    Kopin IJ.
    Adv Neurol; 1987; 45():137-44. PubMed ID: 3493621
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. MPTP: a pharmacological tool to study parkinsonism.
    Kulkarni SK, Mehta AK, Aley KO, Shukla VK.
    Methods Find Exp Clin Pharmacol; 1986 Aug; 8(8):485-9. PubMed ID: 3489146
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Parkinson's disease. A review.
    Voiculescu V.
    Rom J Neurol Psychiatry; 1991 Aug; 29(3-4):103-10. PubMed ID: 1820097
    [No Abstract] [Full Text] [Related]

  • 9. Toxin-induced parkinsonism: recent developments.
    Fruncillo RJ.
    Am Fam Physician; 1986 Mar; 33(3):251-4. PubMed ID: 3485368
    [No Abstract] [Full Text] [Related]

  • 10. [Mechanism of induction of parkinsonism by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a dopaminergic neurotoxin].
    Hirata Y, Nagatsu T.
    Tanpakushitsu Kakusan Koso; 1986 Apr; 31(5):398-409. PubMed ID: 3520683
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Lack of major olfactory dysfunction in MPTP-induced parkinsonism.
    Doty RL, Singh A, Tetrud J, Langston JW.
    Ann Neurol; 1992 Jul; 32(1):97-100. PubMed ID: 1642478
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Parkinsonism and MPTP (methylphenyltetrahydropyridine)].
    Nagatsu T.
    No To Shinkei; 1986 Jul; 38(7):706-7. PubMed ID: 3489476
    [No Abstract] [Full Text] [Related]

  • 17. Development of new pharmacological approaches in Parkinson's disease.
    Carlsson A.
    Adv Neurol; 1987 Jul; 45():513-8. PubMed ID: 3493631
    [No Abstract] [Full Text] [Related]

  • 18. Parkinson's disease.
    Lieberman AN.
    Compr Ther; 1986 Mar; 12(3):25-9. PubMed ID: 3486090
    [No Abstract] [Full Text] [Related]

  • 19. MPTP in animal models of Parkinson's disease.
    Kopin IJ, Schoenberg DG.
    Mt Sinai J Med; 1988 Jan; 55(1):43-9. PubMed ID: 3126391
    [No Abstract] [Full Text] [Related]

  • 20. The MPTP model of Parkinson's disease.
    Smeyne RJ, Jackson-Lewis V.
    Brain Res Mol Brain Res; 2005 Mar 24; 134(1):57-66. PubMed ID: 15790530
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.